OptimizeRx Corporation (OPRX) News
Track canonical SquawkNews coverage tagged to OPRX, OptimizeRx Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
B. Riley Securities maintains Buy rating on OptimizeRx, $11 price target
B. Riley Securities maintained their Buy rating on OptimizeRx's stock with a price target of $11.00.The price target implies an upside of 40.8% from the Sep 28 close of $7.81.Key takeaways from the analyst noteStrong Mar
EQUITY | Sep 29, 2026, 03:55 PM UTC
M
OptimizeRx integrates authenticated EHR point-of-care inventory with OpenPath
OptimizeRx says its authenticated EHR point-of-care inventory will become accessible to advertisers on The Trade Desk via OpenPath, expanding reach to 800,000 verified HCPs. Availability is expected in Q4 2026.
EQUITY | Sep 22, 2026, 12:04 PM UTC
L
OPRX - OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
OPRX - OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
NEWS | Sep 22, 2026, 12:01 PM UTC
L
OPRX - OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
OPRX - OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
EQUITY | Sep 08, 2026, 11:30 AM UTC
L
OptimizeRx adds Troy Sarich to advisor board
OptimizeRx said experienced pharma and healthcare executive Troy Sarich joined its advisory board to help accelerate innovation and strengthen life sciences marketing technology.
EQUITY | Sep 02, 2026, 11:37 AM UTC
L
OptimizeRx appoints Troy Sarich as co-advisor
OptimizeRx appointed Troy Sarich as co advisor.
EQUITY | Sep 02, 2026, 11:30 AM UTC
L
OptimizeRx appoints Troy Sarich as company advisor
OptimizeRx appoints pharma commercial and AI expert Troy Sarich as a company advisor.
EQUITY | Sep 02, 2026, 11:30 AM UTC
L
OptimizeRx Affirms FY2026 Sales Guidance
OptimizeRx affirms FY2026 sales outlook of $95-100 million
EARNINGS | Aug 12, 2026, 08:22 PM UTC
L
OptimizeRx Announces Finance Leadership Appointments
OptimizeRx announces finance leadership appointments to support growth
MNA | Aug 12, 2026, 08:05 PM UTC
L
OptimizeRx Reports Q2 2026 Results
OptimizeRx reports second quarter 2026 financial results and updates fiscal year 2026 guidance
EARNINGS | Aug 12, 2026, 08:01 PM UTC
L
OptimizeRx Sets Q2 Call
OptimizeRx sets Q2 earnings call
EARNINGS | Jul 29, 2026, 11:30 AM UTC
M
OPRX Launches NLAB
OptimizeRx launches Natural Language Audience Builder for life sciences DSPs and agency media planning platforms
EQUITY | Jun 25, 2026, 11:30 AM UTC